Nantahala Capital Management, LLC

Position in CRIS — Curis Inc

CIK 1472322 New Canaan, CT

Position in CRIS

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$1,029,015

-$70,985 QoQ

Shares Held

98,944

-1.1% QoQ

Ownership

4.73%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

of 36 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. CRIS ranks #48 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SVRA	Savara Inc	6,976,810	$42,977,149
2	AVTX	Avalo Therapeutics, Inc.	1,862,250	$34,414,380
3	LBRX	Lb Pharmaceuticals Inc	1,052,894	$34,171,674
4	ABEO	Abeona Therapeutics Inc.	5,136,490	$31,743,508
5	ZVRA	Zevra Therapeutics, Inc.	1,797,476	$25,775,805
6	MLYS	Mineralys Therapeutics, Inc.	820,481	$22,136,577
7	QURE	uniQure N.V.	455,660	$20,987,699
8	AURA	Aura Biosciences, Inc.	2,951,030	$20,952,313

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,029,015	1,978,876	-1.1%	Shares	Sole	2026-08-19
2026-03-31	$1,100,000	2,000,000	+767.3%	Shares	Sole	2026-05-15
2023-03-31	$137,446	230,614	-71.0%	Shares	Sole	2023-05-15
2022-12-31	$437,933	796,241	-76.7%	Shares	Sole	2023-02-14
2022-09-30	$2,434,000	3,420,510	-5.7%	Shares	Sole	2022-11-10
2022-06-30	$3,572,000	3,628,162	+46.4%	Shares	Sole	2022-08-15
2022-03-31	$5,898,000	2,478,265	+3.6%	Shares	Sole	2022-05-13
2021-12-31	$11,384,000	2,391,691	-2.9%	Shares	Sole	2022-02-14
2021-09-30	$19,279,000	2,462,248	+18.2%	Shares	Sole	2021-11-15
2021-06-30	$16,814,000	2,083,536	+25.3%	Shares	Sole	2021-08-16
2021-03-31	$18,822,000	1,662,711	+1.8%	Shares	Sole	2021-05-14
2020-12-31	$13,374,000	1,632,915	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.